These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 506602)

  • 1. [Oral chemical vaccine made from a toxigenic strain of V. cholerae, Ogawa serovar (an experimental study)].
    Dzhaparidze MN; Karaeva LT; Sumarokov AA; Pavlova LP; Marchuk LM
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Oct; (10):62-8. PubMed ID: 506602
    [No Abstract]   [Full Text] [Related]  

  • 2. [Choleragen-anatoxin chemical cholera vaccine enriched with Ogawa O-antigen].
    Dzhaparidze MN; Nikitina GP; Kulikova VL; Popov AA; Naumov AV
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Apr; (4):70-4. PubMed ID: 6204471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
    Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biochemical and immunochemical characteristics of a new oral, chemical cholera bivalent vaccine and results of a trial of the preparation on volunteers].
    Dzhaparidze MN; Nikitina GP; Ivanov NR; Rystsova EA; Udalova IB
    Zh Mikrobiol Epidemiol Immunobiol; 1982; (11):29-33. PubMed ID: 6760628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a recombinant live oral vaccine from a non-toxigenic strain of Vibrio cholerae O1 serotype inaba biotype E1 Tor and assessment of its reactogenicity and immunogenicity in the rabbit model.
    Thungapathra M; Sharma C; Gupta N; Ghosh RK; Mukhopadhyay A; Koley H; Nair GB; Ghosh A
    Immunol Lett; 1999 Jun; 68(2-3):219-27. PubMed ID: 10424424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [O-antigen of Vibrio cholerae, serovar Ogawa, Recommended for the production of oral cholera bivalent vaccine].
    Dzhaparidze MN; Karaeva LT; Sumarokov AA; Marchuk LM; Nikitina GP
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Nov; (11):75-81. PubMed ID: 7324656
    [No Abstract]   [Full Text] [Related]  

  • 7. Construction of a Salmonella typhimurium vaccine strain expressing Vibrio cholera CT-B and LPS-O antigen.
    Chen D; Ma Q
    Chin J Biotechnol; 1997; 13(1):43-50. PubMed ID: 9376506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Strains of Vibrio cholerae serogroups O1 and O139 that produce the basic protective antigens].
    Smirnova NI; Livanova LF; Chekhovskaia GV; Eroshenko GA; Lazovskiĭ IuV; Zakharova TL
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (3):47-51. PubMed ID: 10925874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of the immunogenicity of live virulent and mutant Vibrio cholerae O1 in rabbit intestine.
    Pierce NF; Kaper JB; Mekalanos JJ; Cray WC; Richardson K
    Infect Immun; 1987 Feb; 55(2):477-81. PubMed ID: 3804447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An oral chemical vaccine from the hypertoxigenic strains of the causative agent of cholera KM-76 Inaba and KM-68 Ogawa].
    Dzhaparidze MN; Naumov AV; Nikitina GP; Meleshchenko MV; Dobrova GV; Zavorotnykh VI; Gracheva VP; Zakharova TL
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Apr; (4):31-3. PubMed ID: 1882603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic manipulation of Vibrio cholerae for vaccine development: construction of live attenuated El Tor candidate vaccine strains.
    Benítez JA; Silva AJ; Rodríguez BL; Fando R; Campos J; Robert A; García H; García L; Pérez JL; Oliva R; Torres CA; Ledón T
    Arch Med Res; 1996; 27(3):275-83. PubMed ID: 8854382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of a new strain of Vibrio cholerae O139 as a producer of an enteric chemical vaccine].
    Dzhaparidze MN; Naumov AV; Gromova OV; Adamov AK; Eliseev IuIu; Kosmoenko OM; Kuz'michenko IA; Kopyrzov VN; Zavorotnykh VI; Zakharova TL; Chekhovskaia GV
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (2):52-5. PubMed ID: 8701657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The population composition of cultures of Vibrio cholerae strain 569 B Pakistan in relation to the manufacture of a cholera vaccine (choleragen-anatoxin+O-antigen)].
    Lobanov VV; Nechetskaia RM; Adamova GV
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Aug; (8):73-6. PubMed ID: 2461623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant derivative of a naturally occurring non-toxinogenic Vibrio cholerae 01 expressing the B subunit of cholera toxin: a potential oral vaccine strain.
    Dasgupta U; Bhadra RK; Panda DK; Deb A; Das J
    Vaccine; 1994 Mar; 12(4):359-64. PubMed ID: 8178559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interserovar antitoxic immunity to Vibrio cholerae toxins].
    Belov LG; Adamov AK; Avrorov VP; Kulikova VL; Glian'ko EV
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Jul; (7):43-6. PubMed ID: 3188734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection and immunity to Vibrio cholerae, Salmonella typhimurium and Escherichia coli in a rabbit model.
    Guinée PA; Jansen WH; Rijpkema SG
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 270(1-2):260-9. PubMed ID: 2464884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological responses of rabbits to various somatic and secreted antigens of Vibrio cholerae after intra-duodenal inoculation.
    Kabir S
    J Med Microbiol; 1987 Aug; 24(1):29-40. PubMed ID: 3612742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-associated hemagglutinin-deficient mutant of Vibrio cholerae.
    Finn TM; Reiser J; Germanier R; Cryz SJ
    Infect Immun; 1987 Apr; 55(4):942-6. PubMed ID: 3557620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study of immunological efficacy of the oral chemical cholera vaccine on experimental animals].
    Dzhaparidze MN; Egorova VD; Karaeva LT; Sumarokov AA; Gor'kova Av
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Nov; (11):115-9. PubMed ID: 1007720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.